Disposition kinetic of levofloxacin in experimentally induced febrile model of sheep

Journal of Pharmacology and Toxicology

Volumn 7, Issue 1, 2012, Pages 11-19

  Patel, Urvesh D ^a   Patel, Jatin H ^b   Varia, Rasesh D ^b   Patel, Harshad B ^a   Bhavsar, Shailesh K ^b   Thaker, Aswin M ^c  

^a JUNAGADH AGRICULTURAL UNIVERSITY   (India)

^b Dau Shri Vasudev Chandrakar Kamdhenu Vishwavidyalaya   (India)

^c NAVSARI AGRICULTURAL UNIVERSITY   (India)

Author keywords

Bioavailability; Disposition; Febrile model; Levofloxacin; Sheep

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; LEVOFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FEVER; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; SHEEP; SINGLE DRUG DOSE; STEADY STATE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84857070320     PISSN: 1816496X     EISSN: 2152100X     Source Type: Journal    
DOI: 10.3923/jpt.2012.11.19     Document Type: Article

References (43)

1. Agarwal, A.K., S.D. Singh and C. Jayachandran, 2002. Comparative pharmacokinetics and dosage regimen of amikacin in afebrile and febrile goats. Indian J. Pharmacol., 34: 356-360.
2. Aigbekaen, B.O. and C.E. Oshoma, 2010. Isolation of Enterobacter sakazakii from powdered foods locally consumed in Nigeria. Pak. J. Nutr., 9: 659-663.
3. Albarellos, G.A., L.A. Ambros and M.F. Landoni, 2005. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats. J. Vet. Pharmacol. Ther., 28: 363-369.
4. Ayana, N. and K. Surekha, 2008. Antimicrobial susceptibility pattern and characterization of ciprofloxacin resistant Salmonella enterica serovar Typhi isolates in Kerala, South India. Res. J. Microbiol., 3: 654-660.
5. Bakken, J.S., 2004. The fluoroquinolones: How long will their utility last? Scand. J. Infect. Dis., 36: 85-92.
6. Blondeau, J.M., 1999. Expanded activity and utility of the new fluoroquinolones: A review. Clin. Ther, 21:3-40.
7. Davis, R. and H.M. Bryson, 1994. Levofloxacin: A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 47: 677-700.
8. Dudley, M.N, 1991. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to fluoroquinolones. Am. J. Med, 91: 45S-50S.
9. Dumka, V.K. and A.K. Srivastava, 2006. Pharmacokinetics, urinary excretion and dosing regimen of levofloxacin following a single intramuscular administration in cross bred calves. J. Vet. Sci, 7: 333-337.
10. Dumka, V.K, 2007. Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves. J. Vet. Sci, 8: 357-360.
11. Dumka, V.K. and A.K. Srivastava, 2007a. Disposition kinetics, urinary excretion and dosage regimen of levofloxacin formulation following single intravenous administration in crossbred calves. Vet. Res. Commun, 31: 873-879.
12. Dumka, V.K. and A.K. Srivastava, 2007b. Kinetic disposition, urinary excretion and dosage regimen of subcutaneously administered levofloxacin in cross bred calves. Iran. J. Vet. Res, 8: 313-318.
13. Dumka, V.K, H. Singh, A.K. Srivastava, 2008. Disposition kinetics and urinary excretion of levofloxacin on concomitant administration with meloxicam in cross-bred calves. Environ. Toxicol. Pharmacol, 26: 56-60.
14. Dwivedi, V.K, A. Soni, A. Payasi, A. Ahmad, S.P. Singh and M. Chaudhary, 2011. Potentox reduces biochemical and inflammatory response in osteomyelitis infection. Int. J. Osteoporosis Metab. Disorders, 4: 26-36.
15. Gibaldi, M. and D. Perrier, 1982. Noncompartmental Analysis Based on Statistical Moment Theory. In: Pharmacokinetics, Gibaldi, M. and D. Perrier (Eds.). 2nd Edn., Marcel Dekker, New York, USA, pp: 409-417.
16. Goudah, A, K. Abo-El-Sooud, J.H. Shim, H.C. Shin and A.M. Abd El-Aty, 2008. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration. J. Vet. Pharmacol. Ther, 31: 399-405.
17. Goudah, A, 2009. Pharmacokinetics of levofloxacin in male camels (Camelus dromedarius). J. Vet. Pharmacol. Ther, 2: 296-299.
18. Goudah, A. and K. Abo-El-Sooud, 2009. Pharmacokinetics, urinary excretion and milk penetration of levofloxacin in lactating goats. J. Vet. Pharmacol. Ther, 32: 101-104.
19. Goudah, A. and S. Hasabelnaby, 2010. Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration. Vet. Med. Int., Vol. 2010, 10.4061/2010/727231.
20. Hasegawa, T, K. Takagi and K. Kitaichi, 1999. Effects of bacterial endotoxin on drugs pharmacokinetics. Nagoya J. Med. Sci, 62: 11-28.
21. Iqbal, R, M.A. Zia, T. Iqbal and F. Hussain, 2000. Bio disposition kinetics of levofloxacin in female vlounteers following oral administration. Pak. J. Biol. Sci, 3: 1484-1486.
22. Ismail, M, 2006. A pharmacokinetic study of danofloxacin in febrile goats following repeated administration of endotoxin. J. Vet. Pharmacol. Ther, 29: 313-316.
23. Jernigan, A.D, R.C. Hatch, R.C. Wilson, J. Brown and W.A. Crowell, 1988. Pathologic changes and tissue gentamicin concentrations after intravenous gentamicin administration in clinically normal and endotoxemic cats. Am. J. Vet. Res, 49: 613-617.
24. Langtry, H.D. and H.M. Lamb, 1998. Levofloxacin: its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 56: 487-515.
25. Lode, H, K. Borner and P. Koeppe, 1998. Pharmacodynamics of fluoroquinolones. Clin. Infect. Dis, 27: 33-39.
26. Manikandan, S, S. Ganesapandian, M. Singh and A.K. Kumaraguru, 2011. Emerging of multidrug resistance human pathogens from urinary tract infections. Curr. Res. Bacteriol, 4:9-15.
27. Martinez, M, P. McDermott and R. Walker, 2006. Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals. Vet. J, 172: 10-28.
28. Moniri, R. and K. Dastehgoli, 2007. Antimicrobial resistance among Escherichia coli strains isolated from healthy and septicemic chickens. Pak. J. Biol. Sci, 10: 2984-2987.
29. Naeem, M. and K.K.S. Rafiq, 2006. Determination of residues of quinolones in poultry products by high pressure liquid chromatography. J. Applied Sci, 6: 373-379.
30. Okazaki, O, C. Kojima, H. Hakusui and M. Nakashima, 1991. Enantioselective disposition of ofloxacin in humans. Antimicrob. Agents Chemother, 35: 2106-2109.
31. Patel, U.D, J.H. Patel, S.K. Bhavsar and A.M. Thaker, 2012. Pharmacokinetics of levofloxacin following intravenous and subcutaneous administration in sheep. Asian J. Anim. Vet. Adv., 7: 85-93.
32. Post, L.O, D.E. Farrell, C.V. Cope, J.D. Baker and M.J. Myers, 2003. The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine. J. Pharmacol. Exp. Ther, 304: 889-895.
33. Prasad, V, V. Jain and P.R. Mishra, 2006. Bioavailability enhancement of cyclosporine in rats pretreated with endotoxin. J. Pharmacol. Toxicol, 1: 54-63.
34. Rao, G.S, S. Ramesh, A.H. Ahmad, H.C. Tripathi, L.D. Sharma and J.K. Malik, 2000. Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats. J. Vet. Pharmacol. Ther, 23: 365-372.
35. Sheikh, M.A., S. Khanum, A. Ahmad, T. Iqbal, Z. Hydair and S. Naz, 2001. Study of protein binding of levofloxacin in human beings. J. Medical Sci., 1: 87-90.
36. Sheikh, N.W., A.S. Tripathi, V. Chitra, A. Choudhury and S.P. Dewam, 2010. Excretion of levofloxacin into saliva in renal failure rat model. Int. J. Pharmacol., 63: 944-949.
37. Snedecor, G.W. and W.G. Cochran, 1980. Statistical Methods. 7th Edn., The Iowa State Univ. Press, Ames, IA, Pages: 141.
38. Swoboda, S., K. Oberdorfer, F. Klee, T. Hoppe-Tichy, H. von Baum and H.K. Geiss, 2003. Tissue and serum concentrations of levofloxacin 500 mg administered intravenously or orally for antibiotic prophylaxis in biliary surgery. J. Antimicrob. Chemother., 51: 459-462.
39. Varia, R.D, J.H. Patel, U.D. Patel, S.K. Bhavsar and A.M. Thaker, 2009. Disposition of levofloxacin following oral administration in broiler chickens. Israel J. Vet. Med., 64: 118-121.
40. Verma, D.K. and B.K. Roy, 2006. Milk kinetics of gatifloxacin after single dose intravenous administration in healthy and febrile goats. Indian J. Pharmacol., 38: 366-367.
41. Waheed, N., T. Iqbal, MA. Sheikh and F.H. Khan, 2002. Renal clearance of endogenous creatinine and levofloxacin in male volunteers. J. Medical Sci., 2: 145-148.
42. Walker, R.D., 2000. The use of fluoroquinolones for companion animal antimicrobial therapy. Aus. Vet. J, 78: 84-90.
43. Waxman, S., M.D. San Andres, F. Gonzalez, J.J. De Lucas, M.I. San Andres and C. Rodriguez, 2003. Influence of Escherichia coli endotoxin induced fever on the pharmacokinetic behaviour of marbofloxacin after intravenous administration in goats. J. Vet. Pharmacol. Ther., 26: 65-69.